Improvement in the Regulation of Cellular Cholesterologenesis in Diabetes: the Effect of Reduction in Serum Cholesterol by Simvastatin (Q67899160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827401%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Improvement in the regulation of cellular cholesterologenesis in diabetes: the effect of reduction in serum cholesterol by simvastatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827401%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Improvement in the Regulation of Cellular Cholesterologenesis in Diabetes: the Effect of Reduction in Serum Cholesterol by Simvastatin (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

3 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

3 December 2022

author name string

D. Owens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827401

3 December 2022

J. Stinson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827401

3 December 2022

P. Collins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827401

3 December 2022

A. Johnson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827401

3 December 2022

G. H. Tomkin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827401

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1827401

3 December 2022

publication date

1 February 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827401%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1991.tb01562.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1991.tb01562.x/fullpdf

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

3 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827401%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827401%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827401%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

151-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827401%20AND%20SRC:MED&resulttype=core&format=json

Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Consensus conference. Lowering blood cholesterol to prevent heart disease

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Diabetes and cardiovascular disease. The Framingham study

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Diabetes as an atherogenic factor.

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Low-density lipoproteins modified by lipid transfer protein have altered biological activity

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Cellular cholesterol regulation--a defect in the type 2 (non-insulin-dependent) diabetic patient in poor metabolic control

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

A receptor-mediated pathway for cholesterol homeostasis

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Changes in hepatic and intestinal cholesterol regulatory enzymes. The influence of metformin

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

3 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Cellular cholesterol metabolism in mitogen-stimulated lymphocytes--requirement for de novo synthesis

3 December 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Regulation of cholesterol synthesis by low density lipoprotein in isolated human lymphocytes. Comparison of cells from normal subjects and patients with homozygous familial hypercholesterolemia and abetalipoproteinemia

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Studies in normal subjects

3 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

The submicrosomal localization of acyl-coenzyme A-cholesterol acyltransferase and its substrate, and of cholesteryl esters in rat liver

3 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia

3 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Cholesterol metabolism in alloxan-induced diabetic rabbits

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Stimulation of Acyl-CoA: Cholesterol Acyltransferase Activity by Hyperlipemic Serum Lipoproteins

3 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

3 December 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes

3 December 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

3 December 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01562.X

3 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827401%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference